1128 Journal of Natural Products, 2006, Vol. 69, No. 8
Pokhilo et al.
min. The reaction mixture was cooled, hydrolyzed with 5% HCl (200
mL), and allowed to stand for 12 h. The resulting crude product was
separated, washed with 100 mL of hot H2O, dried, and purified by
column chromatography to give 17 as wine-red needles (1.39 g, 59%):
mp 156-158 °C (lit.14 mp 156-158 °C); 1H NMR (CDCl3, 300 MHz)
δ 1.18 (3H, t, J ) 7.7 Hz, CH3), 2.66 (2H, q, J ) 7.7 Hz, CH2), 7.42
(1H, br s, â-OH), 12.07, 13.60 (each 1H, s, R-OH); 13C NMR (CDCl3,
75 MHz) δ 187.5 (C, C-4), 181.5 (C, C-1), 154.6 (C, C-5), 154.3 (C,
C-8), 153.5 (C, C-2), 135.3 (C, C-6), 131.3 (C, C-7), 127.7 (C, C-3),
109.3 (C, C-4a), 109.0 (C, C-8a), 16.5 (CH2, CH2CH3), 12.5 (CH3,
CH2CH3); EIMS m/z 302/304/306 [M]+ (71), 286/288/290 (83), 285/
287/289 (65), 267/269 (45), 252/254 (35), 244/246 (31), 230 (100);
anal. C 47.64%, H 2.71%, calcd for C12H8Cl2O5, C 47.55%, H 2.66%.
6,7-Dichloro-3-ethyl-5,8-dihydroxy-2-methoxy-1,4-naphthoquin-
one (18). A mixture of hydroxynaphthazarin 17 (400 mg, 1.32 mmol)
and trimethyl orthoformate (30 mL) was refluxed for 12 h. After being
cooled in the refrigerator to 8 °C, the crystals were separated and dried
in vacuo to give methoxynaphthazarin 18 as wine-red prisms (360 mg).
The filtrate was evaporated and the residue was purified by preparative
TLC using n-hexane/acetone (2:1) to give 40 mg of the same product.
263 (25), 250 (23), 248 (24); anal. C 57.27%, H 5.22%, N 4.66%,
calcd for C14H15O6N, C 57.32%, H 5.16%, N 4.78%.
In accordance with general procedure 3, products 1 and 2 were
obtained as dark brown powders (acetone).
3-Amino-7-ethyl-2,5,6,8-tetrahydroxy-1,4-naphthoquinone (echin-
amine A, 1): obtained from 19 (48 mg, 91%); Rf 0.17; mp 245-246
°C; IR (CHCl3) νmax 3522 m, 3445 w, 3379 m (NH2, â-OH), 1650 m,
1603 m (CdO), 1589 s, 1562 s (NH2, CdC) cm-1; 1H NMR (CDCl3,
300 MHz) δ 1.14 (3H, t, J ) 7.5 Hz, CH3), 2.69 (2H, q, J ) 7.5 Hz,
CH2), 5.36 (2H, br s, NH2), 8.49, 9.20 (each 1H, br s, â-OH), 12.62,
13.03 (each 1H, s, R-OH); 13C NMR (CDCl3, 75 MHz) δ 181.7 (C,
C-1), 177.4 (C, C-4), 161.0 (C, C-8), 154.0 (C, C-5), 152.3 (C, C-6),
137.0 (C, C-2), 132.4 (C, C-3), 126.5 (C, C-7), 108.6 (CH, C-4a), 102.6
(C, C-8a), 16.3 (CH2, CH2CH3), 12.9 (CH3, CH2CH3); EIMS m/z 266
[M + 1]+ (44), 265 [M]+ (100), 264 (15), 223 (12), 222 (40).
2-Amino-7-ethyl-3,5,6,8-tetrahydroxy-1,4-naphthoquinone (echin-
amine B, 2): obtained from 20 (37 mg, 69%); Rf 0.19; mp 265-267
°C; IR (CHCl3) νmax 3518 m, 3460 w, 3398 m (NH2, â-OH), 1664 m,
1603 m (CdO), 1580 m, 1560 s (NH2, CdC) cm-1; 1H NMR (CDCl3,
300 MHz) δ 1.13 (3H, t, J ) 7.5 Hz, CH3), 2.67 (2H, q, J ) 7.5 Hz,
CH2), 5.81 (2H, br s, NH2), 8.36, 9.44 (each 1H, br s, â-OH), 13.02
(2H, s, R-OH); 13C NMR (CDCl3, 75 MHz) δ 178.7 (C, C-4), 176.6
(C, C-1), 163.2 (C, C-8), 154.0 (C, C-5), 151.4 (C, C-6), 135.1 (C,
C-3), 134.8 (C, C-2), 124.4 (C, C-7), 107.6 (CH, C-4a), 103.9 (C, C-8a),
16.6 (CH2, CH2CH3), 12.9 (CH3, CH2CH3); EIMS m/z 266 [M + 1]+
(32), 265 [M]+ (77), 250 (25), 237 (17), 222 (100).
1
Total yield of 18 was 94%; mp 138-141 °C; H NMR (CDCl3, 500
MHz) δ 1.14 (3H, t, J ) 7.1 Hz, CH3), 2.65 (2H, q, J ) 7.1 Hz, CH2),
4.17 (3H, s, OCH3), 12.86, 13.32 (each 1H, s, R-OH); 13C NMR (CDCl3,
125 MHz) δ 181.9 (C, C-4), 177.4 (C, C-1), 159.5 (C, C-8), 158.8 (C,
C-5), 157.2 (C, C-2), 138.3 (C, C-3), 135.5 (C, C-7),15 134.1 (C, C-6),15
110.0 (C, C-8a), 108.9 (C, C-4a), 61.8 (CH3, OCH3), 17.0 (CH2, CH2-
CH3), 13.2 (CH3, CH2CH3); EIMS m/z 316/318/320 [M]+ (100), 301/
303/305 (73), 283/285/287 (10), 273/275/277 (15); anal. C 49.54%, H
3.23%, calcd for C13H10Cl2O5, C 49.23%, H 3.18%.
3-Bromo-5,8-dihydroxy-2,7-dimethoxy-1,4-naphthoquinone (26).
To a stirred solution of 5,8-dihydroxy-2,7-dimethoxy-1,4-naphtho-
quinone (3) (250 mg, 1.0 mmol) in 60 mL of AcOH was added dry
bromine (325 µL). The reaction mixture was kept at room temperature
for 48 h and monitored by TLC (n-hexane/acetone, 2:1). Then the
reaction mixture was diluted with H2O and extracted with EtOAc. The
organic layer was washed with water and brine, dried over Na2SO4,
and concentrated, and the product was isolated by preparative TLC
(n-hexane/acetone, 2:1) as a red-brown solid (118 mg, 36%): Rf 0.42;
mp >230 °C (dec); IR (CCl4) νmax 2856 s, 1614 s, 1602 s (CdO),
In accordance with general procedure 1, products 11 and 12 were
obtained as red solids.
3-Chloro-7-ethyl-5,8-dihydroxy-2,6-dimethoxy-1,4-naphthoquin-
one (11): 156 mg (50%); Rf 0.62; mp 137-139 °C (acetone); 1H NMR
(CDCl3, 500 MHz) δ 1.15 (3H, t, J ) 7.5 Hz, CH3), 2.69 (2H, q, J )
7.5 Hz, CH2), 4.12, 4.25 (each 3H, s, OCH3), 13.09, 13.14 (each 1H s,
R-OH); 13C NMR (CDCl3, 125 MHz) δ 172.5 (C, C-4), 170.6 (C, C-1),
168.4 (C, C-5), 166.2 (C, C-8), 156.6 (C, C-2), 156.2 (C, C-6), 137.0
(C, C-3), 126.0 (C, C-7), 108.3 (C, C-8a), 108.5 (C, C-4a), 61.9 (CH3,
C-6-OCH3), 61.6 (CH3, C-2-OCH3), 17.0 (CH2, CH2CH3), 13.4 (CH3,
CH2CH3); EIMS m/z 312/314 [M]+ (100), 311/313 (92), 297/299 (12),
296/298 (25), 294 (10), 293 (11), 256 (9); anal. C 53.79%, H 4.30%,
calcd for C14H13ClO6, C 53.84%, H 4.20%.
6-Chloro-3-ethyl-5,8-dihydroxy-2,7-dimethoxy-1,4-naphthoquin-
one (12): 81 mg (26%); Rf 0.59; mp 129-131 °C (acetone); 1H NMR
(CDCl3, 500 MHz) δ 1.17 (3H, t, J ) 7.5 Hz, CH3), 2.71 (2H, q, J )
7.5 Hz, CH2), 4.11, 4.22 (each 3H, s, OCH3), 12.83, 13.34 (each 1H,
s, R-OH); 13C NMR (CDCl3, 125 MHz) δ 171.8 (C, C-4), 169.3 (C,
C-5), 169.0 (C, C-1), 167.8 (C, C-8), 156.1 (C, C-2), 155.3 (C, C-7),
138.2 (C, C-3), 127.6 (C, C-6), 110.3 (C, C-8a), 106.6 (C, C-4a), 61.8
(CH3, C-7-OCH3), 61.6 (CH3, C-2-OCH3), 17.3 (CH2, CH2CH3), 13.5
(CH3, CH2CH3); EIMS m/z 312/314 [M]+ (100), 311/313 [M - 1]+-
(70), 297/299 (27), 296/298 (30), 278 (12), 223 (16); anal. C 53.77%,
H 4.28%, calcd for C14H13ClO6, C 53.84%, H 4.20%.
1
1570 m, 1554 m, 1550 m (CdC) cm-1; H NMR (CDCl3, 500 MHz)
δ 3.96, 4.18 (each 3H, s, OCH3), 6.34 (1H, s, Harom), 12.67, 13.37 (each
1H, s, R-OH); 13C NMR (CDCl3, 125 MHz) δ 177.7 (C, C-4), 171.4
(C, C-1), 164.4 (C, C-5), 163.4 (C, C-8), 159.7 (C, C-2), 156.0 (C,
C-7), 120.2 (C, C-3), 111.3 (C, C-8a), 108.9 (CH, C-6), 105.5 (C, C-4a),
61.5 (CH3, C-7-OCH3), 56.9 (CH3, C-2-OCH3); EIMS m/z 328/330
[M]+ (92), 330 (33), 237 (62), 236 (100).
3-Chloro-2,5,6,8-tetrahydroxy-1,4-naphthoquinone (25). A mix-
ture of dichloronaphthazarin 8 (2.0 g, 7.9 mmol), H3BO3 (1.0 g, 16.1
mmol), and 20 mL of concentrated H2SO4 was heated at 210-220 °C
for 20 min. After being cooled the reaction mixture was diluted with
H2O. The solid was separated, dried in vacuo, and diluted with EtOAc
(1 L). Then this solution was filtered through the column with silica
gel and dried over Na2SO4, and the product was isolated by column
chromatography (n-hexane/acetone, 2:1) as a dark wine-red powder
(1.4 g, 69%): mp 227-230 °C (dec); 1H NMR (acetone-d6, 300 MHz)
δ 6.62 (1H, s, Harom), 10.07, 10.52 (each 1H, br s, â-OH), 12.29, 13.00
(each 1H, s, R-OH); 13C NMR (CDCl3, 125 MHz) δ 180.1 (C, C-4),
174.8 (C, C-1), 166.0 (C, C-6), 159.3 (C, C-8), 157.6 (C, C-2), 154.1
(C, C-5), 116.8 (C, C-3), 110.4 (C, C-4a), 109.1 (CH, C-7), 105.1 (C,
C-8a); EIMS m/z 256/258 [M]+ (100), 228/230 (42), 200 (5), 193 (12),
188 (6), 186 (17), 158 (7); anal. C 47.02%, H 2.02%, calcd for C10H5-
ClO6, C 46.81%, H 1.96%.
7-Chloro-5,8-dihydroxy-2,6-dimethoxy-1,4-naphthoquinone (23):
obtained by reaction of corresponding naphthazarin 25 (0.5 mmol) in
Et2O with a solution of CH2N2 in Et2O monitored by TLC. The reaction
mixture was concentrated in vacuo to give a residue, which was purified
by preparative TLC (n-hexane/acetone, 3:1). Compound 23: dark red
needles; yield 110 mg (78%); Rf 0.43; mp 190-194 °C; 1H NMR
(CDCl3, 500 MHz) δ 3.97, 4.26 (each 3H, s, OCH3), 6.35 (1H, s, Harom),
13.03, 13.09 (each 1H, s, R-OH); 13C NMR (CDCl3, 125 MHz) δ 177.4
(C, C-4), 168.6 (C, C-1),15 167.2 (C, C-8),15 163.6 (C, C-5), 160.2 (C,
C-2), 156.3 (C, C-6), 124.9 (C, C-7), 108.6 (C, C-8a), 108.3 (CH, C-3),
107.7 (C, C-4a), 61.9 (CH3, C-6-OCH3), 56.9 (CH3, C-2-OCH3); EIMS
m/z 284/286 [M]+ (100), 283/285 [M - 1]+ (92), 266/268 (25), 255
(19), 249 (12), 236 (9); anal. C 50.50%, H 3.45%, calcd for C12H9-
ClO6, C 50.63%, H 3.19%.
In accordance with general procedure 2, products 19 and 20 were
obtained as yellow-brown needles.
3-Amino-7-ethyl-5,8-dihydroxy-2,6-dimethoxy-1,4-naphthoquin-
one (19): obtained from 11 (63 mg, 43%); Rf 0.32; mp 300 °C (dec);
IR (CHCl3) νmax 3514 m, 3398 m (NH2), 1684 w, 1641 m, 1616 m
(CdO), 1593 s, 1556 s (NH2, CdC) cm-1; 1H NMR (CDCl3, 500 MHz)
δ 1.17 (3H, t, J ) 7.6 Hz, CH3), 2.74 (2H, q, J ) 7.6 Hz, CH2), 4.00,
4.01 (each 3H, s, OCH3), 5.06 (2H, br s, NH2), 12.52, 13.48 (each 1H,
s, R-OH); EIMS m/z 293 [M]+ (100), 292 (30), 278 (76), 263 (22),
250 (31), 248 (37), 235 (27), 221 (26); anal. C 57.25%, H 5.25%, N
4.90% calcd for C14H15O6N, C 57.32%, H 5.16%, N 4.78%.
3-Amino-6-ethyl-5,8-dihydroxy-2,7-dimethoxy-1,4-naphthoquin-
one (20): obtained from 12 (66 mg, 45%); Rf 0.36; mp 118-120 °C;
IR (CHCl3) νmax 3514 m, 3396 m (NH2), 1639 m, 1618 m (CdO),
1
1590 s, 1555 (NH2, CdC) cm-1; H NMR (CDCl3, 500 MHz) δ 1.15
(3H, t, J ) 7.5 Hz, CH3), 2.69 (2H, q, J ) 7.5 Hz, CH2), 3.99, 4.06
(each 3H, s, OCH3), 5.17 (2H, br s, NH2), 12.67, 13.56 (each 1H, s,
R-OH); 13C NMR (CDCl3, 125 MHz) δ 181.1 (C, C-1), 181.2 (C, C-4),
159.6 (C, C-5), 156.3 (C, C-7), 153.4 (C, C-8), 140.5 (C, C-3), 136.5
(C, C-2), 133.5 (C, C-6), 108.7 (C, C-8a), 106.4 (C, C-4a), 61.4 (CH3,
C-7-OCH3), 60.4 (CH3, C-2-OCH3), 17.0 (CH2, CH2CH3), 13.6 (CH3,
CH2CH3); EIMS m/z 293 [M]+ (100), 292 (86), 279 (22), 278 (86),
In accordance with general procedure 2, products 24 and 27 were
obtained as yellow-brown powders.